Bottom line
JDOC vs SCHLX: the short answer
JDOC (JPMorgan Healthcare Leaders ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 65% by weight.
JDOC is cheaper at 0.65% vs 1.06% — a difference of $41 a year per $10,000 invested.
Updated Nov 19, 2026
JDOC vs SCHLX side by side
| JDOC | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | J.P. Morgan | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.65% | 1.06% |
| Annual cost per $10k | $65 | $106 |
| 10-yr cost on $10k (prospectus) | $810 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +14.9% | — |
| 5-yr return (annualized) | — | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +11.3% | — |
| Worst quarter | −11.9% | — |
| Net assets (fund) | $9.1M | $231.8M |
| Number of holdings | 61 | 65 |
| Portfolio turnover | 92% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
16 of JDOC's top 25 holdings also appear in SCHLX's top 25.
| Holding | JDOC | SCHLX |
|---|---|---|
| AbbVie, Inc. | 7.85% | 4.90% |
| Eli Lilly & Co. | 7.76% | 13.85% |
| UnitedHealth Group, Inc. | 5.85% | 5.73% |
| Merck & Co., Inc. | 4.82% | 4.85% |
| Johnson & Johnson | 4.82% | 6.19% |
| AstraZeneca plc | 3.76% | 3.80% |
| Thermo Fisher Scientific, Inc. | 3.73% | 3.46% |
| Bristol-Myers Squibb Co. | 3.57% | 1.50% |
| Abbott Laboratories | 3.11% | 2.39% |
| Roche Holding AG | 2.82% | 1.24% |
| Stryker Corp. | 2.23% | 2.61% |
| Danaher Corp. | 2.16% | 2.13% |
| Cencora, Inc. | 2.07% | 1.26% |
| Intuitive Surgical, Inc. | 1.93% | 2.69% |
| Regeneron Pharmaceuticals, Inc. | 1.60% | 1.43% |
Source: SEC Form N-PORT
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between JDOC and SCHLX?
JDOC (JPMorgan Healthcare Leaders ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 65% by weight. JDOC is cheaper at 0.65% vs 1.06% — a difference of $41 a year per $10,000 invested.
Which is cheaper, JDOC or SCHLX?
JDOC has the lower expense ratio (0.65%).
Should I own both JDOC and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.